
Patient-Directed Record Access: TEFCA, Consent and Provider Responsibilities
Dr. Dereck Mush, MD, MBAPress release · Company announcement
Equiti
28 October 2026
Strategic acquisition strengthens Equiti's AI-powered language access platform with advanced real-time interpretation technology, expanding access for more than 68 million people with limited English proficiency
SAN FRANCISCO, Oct. 28, 2026 - Equiti, the AI-powered language access platform transforming how healthcare organizations communicate with patients, today announced it has acquired Lexi AI, a pioneering AI medical interpretation technology. The acquisition strengthens Equiti's position as the most comprehensive language access solution in healthcare, combining Lexi's advanced AI capabilities with Equiti's established platform serving hundreds of hospitals and health systems nationwide.
"Language should never be a barrier to quality healthcare," said Dr. Ankit Sanghavi, Founder and CEO of Equiti. "By bringing Lexi's sophisticated AI interpretation technology into the Equiti platform, we're accelerating our mission to make language access seamless, scalable, and available exactly when patients and providers need it. This acquisition represents a significant leap forward in our ability to serve the 68 million people in the U.S. with limited English proficiency."
Lexi AI has developed groundbreaking technology that delivers real-time medical interpretation across multiple languages with clinical-grade accuracy. The company's AI models are specifically trained on medical terminology and healthcare workflows, enabling them to handle complex clinical conversations with the precision and nuance that healthcare settings demand.
“We've always believed that AI can transform language access in healthcare, but only when it's built specifically for clinical environments,”
— Dr. Rishi Khanna, Founder and CEO of Lexi AI, who will join Equiti as Chief AI Officer. "Equiti shares our commitment to clinical excellence and patient safety. Together, we can bring AI-powered interpretation to every healthcare interaction that needs it."
The acquisition comes at a critical time for healthcare language access. As health systems face mounting pressure to improve health equity outcomes while managing costs, AI-powered solutions offer a path to scale language services without sacrificing quality. Equiti's platform already integrates human interpreters with AI capabilities, and Lexi's technology will enhance the AI layer to handle a broader range of clinical scenarios with greater accuracy.
Key benefits of the combined platform include:
“This acquisition positions Equiti to solve one of healthcare's most persistent challenges,”
— Sanghavi. "Every day, patients struggle to communicate with their care teams, leading to delayed care, medication errors, and poorer outcomes. Our combined technology means that language access can finally be available 24/7, in every care setting, at a cost that makes universal access achievable."
The Lexi AI team will integrate into Equiti's product and engineering organizations, with Khanna leading AI strategy and development. Financial terms of the acquisition were not disclosed.
Equiti is the AI-powered language access platform that helps healthcare organizations communicate effectively with patients who have limited English proficiency. Serving hundreds of hospitals and health systems across the United States, Equiti combines advanced AI technology with a network of certified medical interpreters to deliver accurate, culturally competent language access at scale. Learn more at https://equitihealth.com.
Lexi AI develops AI-powered medical interpretation technology designed specifically for healthcare environments. The company's clinical-grade AI models deliver real-time interpretation across multiple languages with the accuracy and medical terminology expertise that healthcare conversations require. Learn more at https://www.withlexi.com.

Dr. Dereck Mush, MD, MBA
Dr. Dereck Mush, MD, MBA
Dr. Dereck Mush, MD, MBA
Dr. Dereck Mush, MD, MBAKeep exploring